Dana-Farber May Retract, Correct Over 30 Cancer Papers
Dana-Farber Cancer Institute is investigating allegations of data manipulation in dozens of research papers, some of which were authored by high-profile investigators.
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dana-Farber Cancer Institute is investigating allegations of data manipulation in dozens of research papers, some of which were authored by high-profile investigators.
A post hoc analysis of three clinical trials shows the drug works within weeks to improve bowel function and abdominal symptoms in people with IBS-C.
A new study challenged the policy of some opioid addiction treatment programs that require patients to abstain from cannabis before therapy can begin.
Media reports touting ketamine as a miracle drug for severe depression have contributed to confusion about the differences between ketamine and its esketamine, experts said.
Accelus closed a $20 million debt facility from Symbiotic Capital, according to a Jan. 18 news release.